Picture of Biotest AG logo

BIO3 Biotest AG Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Annual cashflow statement for Biotest AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-26-6-1.3-30-62.7
Depreciation
Non-Cash Items54.116.51.12517.5
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-16.1-85.2-65.1-41.348
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities34.3-50-33.6-16.733.9
Capital Expenditures-107-54.6-34.1-27-18.2
Purchase of Fixed Assets
Other Investing Cash Flow Items-41.525526.112.4-5.2
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-148201-8-14.6-23.4
Financing Cash Flow Items-1.1-15.22.70.13.6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities55.2-11140.54222.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-58.739.6-1.110.533.1

Or unlock with your email

Or unlock with your email